Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review-Reference-Cited by-同舟云学术

Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review

Published:2021-12-19 Issue: Volume: Page:1-7
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Ramadan Mohammad Said¹^ORCID,Gallo Raffaella¹,Lugarà Marina²,Gambardella Michele³,Oliva Gabriella²,Bertolino Lorenzo¹,Andini Roberto⁴,Coppola Nicola⁵,Zampino Rosa⁴⁶^ORCID,Durante-Mangoni Emanuele¹⁴^ORCID

Affiliation:

1. Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

2. Unit of Internal Medicine, Ospedale del Mare, Naples, Italy

3. Infectious Diseases Unit, Ospedale S. Luca, Vallo della Lucania, Italy

4. Unit of Infectious & Transplant Medicine, A.O.R.N. Ospedali dei Colli - Ospedale Monaldi, Naples, Italy

5. Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

6. Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2021.2015649

Reference21 articles.

1. Current trends in the real-life use of dalbavancin: report of a study panel

2. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new

3. Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

4. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report for 2019; [cited 2020]. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019#no-link

5. Dalbavancin for infective endocarditis: a single centre experience

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of dalbavancin in early discharge and non-hospitalization. It’s time to throw your heart over the obstacle?;Global and Regional Health Technology Assessment;2024-07-29

2. Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis;Open Forum Infectious Diseases;2024-02-07

3. A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections;Antibiotics;2023-09-28

4. Dalbavancin in Bone and Joint Infections: A Systematic Review;Pharmaceuticals;2023-07-15

5. Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience;Antibiotics;2022-10-08